- Home
- SEDG vs XNCR Comparison
SEDG vs XNCR Comparison
Compare SEDG & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEDG | XNCR |
|---|---|---|
| Founded | 2006 | 1997 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2015 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SEDG | XNCR |
|---|---|---|
| Price | $23.94 | $37.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 24 | 14 |
| Target Price | $30.94 | ★ $42.50 |
| AVG Volume (30 Days) | ★ 2.7M | 1.6M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.26 | 65.36 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,184,444,000.00 | $125,576,000.00 |
| Revenue This Year | $5.83 | $57.39 |
| Revenue Next Year | $1.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 31.39 | 13.65 |
| 52 Week Low | $24.33 | $10.38 |
| 52 Week High | $81.25 | $40.60 |
Technical Indicators
Market Signals| Indicator | SEDG | XNCR |
|---|---|---|
| Relative Strength Index (RSI) | 32.71 | 69.59 |
| Support Level | N/A | $22.80 |
| Resistance Level | $34.41 | N/A |
| Average True Range (ATR) | 2.24 | 2.07 |
| MACD | -0.59 | 0.74 |
| Stochastic Oscillator | 6.99 | 75.23 |
Price Performance
Historical ComparisonAbout SEDG SolarEdge Technologies Inc.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.